|
🐬
|
Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients’ perspectives of the disease and treatment
A. Russell,
E. Ripamonti,
C. Vancheri
|
6 |
2016 |
6
🐬
|
|
🐜
|
Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries
8 auth.
T. Maher,
M. Molina-Molina,
A. Russell,
F. Bonella,
S. Jouneau,
E. Ripamonti,
...
J. Axmann,
C. Vancheri
|
6 |
2017 |
6
🐜
|
|
🐜
|
Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor
11 auth.
M. Figini,
F. Martin,
R. Ferri,
E. Luison,
E. Ripamonti,
A. Zacchetti,
...
M. Mortarino,
V. Cioccio,
G. Maurizi,
M. Allegretti,
S. Canevari
|
4 |
2009 |
4
🐜
|
|
🐜
|
Exploring predictors of work competence in schizophrenia: The role of theory of mind
11 auth.
M. Bechi,
M. Spangaro,
A. Pigoni,
E. Ripamonti,
M. Buonocore,
F. Cocchi,
...
L. Bianchi,
C. Guglielmino,
A. Mastromatteo,
R. Cavallaro,
M. Bosia
|
3 |
2019 |
3
🐜
|
|
🦁
|
Measurement of respiratory function decline in patients with Duchenne muscular dystrophy: a conjoint analysis.
E. Ripamonti,
G. D'angelo
|
1 |
2018 |
1
🦁
|
|
🦁
|
Pioglitazone and bladder cancer: improving research methods
E. Ripamonti,
L. Azoulay,
M. Abrahamowicz,
R. Platt,
S. Suissa
|
1 |
2020 |
1
🦁
|
|
🐜
|
P161 Unmet needs in the treatment of idiopathic pulmonary fibrosis (IPF) – insights from patient chart review in five european countries
8 auth.
T. Maher,
M. Molina-Molina,
A. Russell,
F. Bonella,
S. Jouneau,
E. Ripamonti,
...
J. Axmann,
C. Vancheri
|
1 |
2016 |
1
🐜
|
